Fact sheet: JPM Gbl Healthcare

Fund information

Fund name
JPM Global Healthcare A Acc NAV USD
Fund company manager
JPMorgan Asset Mgmt (Europe) S
Fund type
SIB
Fund manager(s)
Premal PAJWANI
since 24/06/2014
Anne Marden
since 20/10/2009
Matthew Cohen
since 05/01/2015
Fund objective
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

17.85 %

1 Year rank in sector

10/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.9 b

FE Risk score

149

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    70.4%
  • Europe & Middle East
    22.8%
  • UK
    4.5%
  • Money Market
    1.2%
  • Japan
    1.1%
  • Biotechnology/Medical
    49.4%
  • Pharmaceuticals
    31%
  • Health Care
    18.4%
  • Money Market
    1.2%
  • North American Equities
    70.4%
  • International Equities
    22.8%
  • UK Equities
    4.5%
  • Money Market
    1.2%
  • Japanese Equities
    1.1%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-0.17 %10.87 %17.85 %16.28 %97.59 %
Sector1.18 %8.1 %14.79 %27.68 %100.39 %
Rank within sector29 / 3112 / 3110 / 3022 / 2812 / 24
Quartile th4 th2 nd2 nd4 th2 nd

Calendar performance

YTD-20172016201520142013
Fund20.42 %-15.42 %2.14 %22.01 %61.04 %
Sector17.13 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector12 / 3022 / 3023 / 2820 / 254 / 24
Quartile th2 nd3 rd4 th4 th1 st

Risk statistics

Alpha-3.02
Beta0.89
Sharpe-0
Volatility14.24
Tracking error4.1
Information ratio-0.89
R-Squared0.93

Price movement

52 week high307.08
52 week low241.05
Current bid price0
Current offer price0
Current mid price302.37

Holdings by region

  • 70.4% North America
  • 22.8% Europe & Middle East
  • 4.5% UK
  • 1.2% Money Market
  • 1.1% Japan

Holdings by sector

  • 49.4% Biotechnology/Medical
  • 31% Pharmaceuticals
  • 18.4% Health Care
  • 1.2% Money Market

Holdings by asset type

  • 70.4% North American Equities
  • 22.8% International Equities
  • 4.5% UK Equities
  • 1.2% Money Market
  • 1.1% Japanese Equities

Individual holdings

  • 6.2% UNITEDHEALTH GROUP INC
  • 5.4% ROCHE HLDG AG
  • 4.3% CELGENE CORP
  • 3.5% BAYER AG
  • 3.2% ALLERGAN INC
  • 3% LILLY (ELI) & CO
  • 2.9% SANOFI
  • 2.9% SHIRE PLC
  • 2.8% BRISTOL MYERS SQUIBB SA
  • 2.7% VERTEX PHARMACEUTICAL